Jeffrey C Lightcap bought $1.1M of Heartflow (HTFL)
Executed Dec 16 2025, disclosed Dec 17 2025, 1 day later.
Over the 21 trading sessions from the disclosed entry session (Dec 17 2025), the stock returned +41.2% (delay-adjusted); from the execution session (Dec 16 2025), +40.3%. Derived: entry at the session's open, exit at the close 20 sessions later.
Jeffrey C Lightcap (Director) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in Heartflow, Inc. (HTFL). Across 1 priced purchase filing, the average 21-session return was +40.3% from execution and +41.2% from disclosure (delay-adjusted; derived). The largest single filing was $1.1M of HTFL (40,000 sh × $26.34, as filed), executed Dec 16 2025.
Healthcare · HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases the Uni…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→